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 The alteration of a microbial environment by introduction of a new xenobiotic chemical leads to the 
evolution of new metabolic pathways so that the microbes can detoxify them and utilize them as carbon 
sources. Pentachlorophenol (PCP) is a toxic pollutant that was introduced into the environment in the 
1930’s. The Gram-negative bacterium Sphingobium chlorophenolicum strain [L-1 ATCC 53874] was 
isolated from soil contaminated with PCP and has been observed to be able to degrade PCP.  
 The first enzyme in the PCP degradation pathway in this bacterium, PCP hydroxylase, catalyzes the 
rate-limiting step in the pathway. Along with its poor efficiency, this enzyme is inactivated by its product, 
tetrachlorobenzoquinone (TCBQ). It is suggested that this inactivation occurs as a result of the covalent 
attachment of TCBQ to cysteine residues on the enzyme.  
 I have found that changing cysteine residues 302 and 537 to serines does not significantly affect the 
activity of the enzyme, and changing cysteine residue 537 to serine slightly reduced the degree of 
inactivation by TCBQ. The C537S mutant version of the enzyme was about three-fold inactivated, while 
the wild type version was about four-fold inactivated. 
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Chapter 1: Background 
The introduction of new toxic xenobiotic compounds leads to the evolution of new metabolic 
pathways that degrade these compounds to detoxify them and potentially allow the organism to utilize 
these compounds as carbon sources. Pentachlorophenol (PCP) has been used as a pesticide and wood 
preservative since the 1930’s. Since PCP is a polychlorinated aromatic compound, PCP is highly resistant 
to degradation. Thus, PCP has been accumulating in the environment since the start of the use of PCP by 
humans and has not been efficiently removed from the environment by microorganisms. PCP is now 
recognized as a major environmental pollutant by the EPA and is highly toxic in that PCP uncouples 
electron transport and oxidative phosphorylation and perturbs membrane properties (Copley, 2000, 
Tiirola, et. al., 2002).  
The Gram-negative bacterium Sphingobium chlorophenolicum strain [L-1 ATCC 53874], having 
been isolated from soil contaminated with PCP, is one of the few bacteria that can degrade PCP. Although 
mono- and dichlorophenols are naturally produced by fungi and insects, PCP has not been naturally 
produced, so the recent introduction of PCP into the environment by humans is the first exposure 
microbes have had to PCP. Having only been exposed to PCP for a short time by evolutionary standards, 
the bacterium has not had sufficient time to develop an efficient PCP degradation pathway, so this 
pathway is very imperfect (Crawford, et. al., 2007, Dai, et. al., 2003, Tiirola, et. al., 2002). The 
bacterium’s ability to degrade PCP is hindered at higher concentrations of PCP, and the bacterium does 
not survive concentrations of 60 mg/L of PCP or higher (Tiirola, et. al., 2002, Yang, et. al., 2006). 
Engineering the pathway to be more efficient and utilizing the pathway would be an ideal way to clear 
PCP from the environment. 
 The first enzyme in the S. chlorophenolicum PCP degradation pathway is the flavoprotein PCP 
hydroxylase (PcpB), which catalyzes the hydroxylation of PCP para to the hydroxyl group, producing 
tetrachlorobenzoquinone (TCBQ). This step requires NADPH and O2. PcpD catalyzes the reduction of 
TCBQ to tetrachlorohydroquinone (TCHQ). This step also requires NADPH. TCHQ then undergoes two 
dechlorination steps, catalyzed by PcpC. The resulting aromatic ring is cleaved by PcpA. The cleaved 
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product undergoes multiple other steps to be completely oxidized to form carbon dioxide and 
hydrochloric acid (Figure 1). 
 
 
Figure 1. PCP degradation pathway in S. chlorophenolicum. PcpB, PCP hydroxylase; PcpD, TCBQ 
reductase; PcpC, TCHQ dehalogenase; PcpA, 2,6-dichlorohydroquinone dioxygenase. 
 
 PcpB requires a flavin cofactor and NADPH and O2 as substrates. The flavin is reduced by 
NADPH. O2 is then added to the reduced flavin anion, forming a peroxy-flavin intermediate. PCP de-
aromatizes, and the activated carbon para to the hydroxyl group serves as a nucleophile to obtain the 
hydroxyl group from the peroxy-flavin. Since chloride is a better leaving group than hydroxide, the 
chloride leaves. The proton of the newly added hydroxyl group is extracted by the flavin, and the ring 
forms tetrachlorobenzoquinone. After the dissociation of the TCBQ, the C4a-hydroxyflavin eliminates 
water to regenerate the oxidized flavin ready for the next catalytic cycle (Figure 2). 
 
Involvement of Cysteine Residues in the Function and Inactivation of PCP Hydroxylase  6 
 
 
Figure 2. Mechanism of PCP hydroxylase. 
 
 The step catalyzed by PcpB is the rate-limiting step in the pathway because PcpB is quite 
inefficient. This enzyme has probably not yet evolved to its optimal performance, which may be partly 
due its broad specificity. Many other polyhalogenated phenols besides PCP are also substrates for this 
enzyme (Copley, 2000, Tiirola, et. al., 2002).  
 Another negative attribute of this enzyme is that the enzyme allows for futile cycling of NADPH. 
In this case, NADPH is wasted as the peroxy-flavin dissociates into flavin and hydrogen peroxide. Also, 
because of the broad specificity of the enzyme, TCHQ can be a substrate for the enzyme. The mechanism 
is the same as that for PCP, but the TCHQ forms an intermediate with two hydroxyl groups in the 
position para to the original hydroxyl group on PCP. One of the two hydroxyl groups leaves, forming 
TCBQ. Since TCHQ is a downstream metabolite of TCBQ in the PCP degradation pathway in S. 
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chlorophenolicum, the conversion of TCHQ back to TCBQ by PcpB makes the progression of PCP and 
its metabolites through the pathway less efficient by unnecessarily undergoing the rate-limiting step in the 
pathway and going backwards in the pathway. Also, the use of TCHQ as a substrate by PcpB wastes 
NADPH by unnecessarily oxidizing NADPH in the conversion of TCHQ to TCBQ and then having to re-
reduce TCBQ to TCHQ using NADPH via catalysis by PcpD. However, the ability of PcpB to use TCHQ 
as a substrate is not proven.  
Another undesirable feature is that the enzyme is permanently inactivated by its own product, 
TCBQ. When the enzyme is inactivated, the number of free cysteine residues in the enzyme decreases, 
suggesting that the TCBQ inactivates the enzyme by interacting with the cysteine residues. TCBQ may 
inactivate the enzyme by covalently attaching to the cysteine residues in the enzyme (Figure 3). However, 
this attachment to cysteine residues is not yet proven. It may also be the case that TCBQ is involved in the 
oxidation of cysteine residues that must be reduced in order for the enzyme to perform catalysis. TCBQ 
may catalyze the oxidation of the cysteine residues or may itself react with other compounds in solution, 
which may lead to the oxidation of the cysteine residues. It seems that the covalent attachment of TCBQ 
to the cysteine residues is more likely because the aromaticity of TCBQ makes TCBQ a good 
electrophilic target for a nucleophilic thiol.  
It has been observed that many aromatic hydroxylases using this type of mechanism with flavin 
are inhibited by monovalent anions, such as chloride and azide. Because chloride ions are generated in the 
conversion of PCP to TCBQ, it may be possible that the accumulation of chloride ions in solution 
accounts for the inhibition of PcpB as the reaction proceeds. However, it is unlikely that inhibition by 
chloride ions is the cause of the inactivation of PcpB. From observations of other aromatic hydroxylases 
using flavin, monovalent anions appear to perturb the C4a-hydroxyflavin intermediate and inhibit the 
elimination of water from this intermediate, preventing the regeneration of oxidized flavin for the next 
catalytic cycle (Detmer and Massey, 1984; Maeda-Yorita and Massey, 1993). Because these enzymes 
manage to proceed to the formation of the C4a-hydroxyflavin intermediate at all, it appears that 
monovalent anions do not exhibit inhibitory effects early in the catalytic cycle. The inhibitory effect only 
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occurs upon the formation of the C4a-hydroxyflavin intermediate, which requires NADPH. However, the 
inactivation of PcpB has been observed due to treatment of the enzyme with TCBQ alone. Even if 
chloride ions were to form in solution, perhaps due to the reaction of TCBQ with water, chloride ions are 
not responsible for the observed inactivation of PcpB by TCBQ because NADPH is not in solution during 
incubation with TCBQ.  Any chloride ions that may possibly form during the incubation with TCBQ are 
removed before the enzyme can Also, Detmer and Massey (1984) report that inhibition of phenol 
hydroxlase by chloride ions is reversible, whereas inactivation of PcpB by TCBQ is permanent.  
Attachment of TCBQ to cysteine resiues near the active site might interfere with the ability of 
PCP or NADPH to bind to the active site or might interfere with the conformational changes involved in 
the catalysis. If the enzyme is inactivated by the attachment of TCBQ to a cysteine residue close to the 
active site, then this would suggest that TCBQ may competitively inhibit PCP from entering the active 
site or may interfere with conformational changes required for catalysis. If the enzyme gets inactivated by 
the attachment of TCBQ to a cysteine residue far from the active site, then this would suggest that the 
TCBQ affects the conformation of the enzyme or its ability to undergo the necessary conformational 
changes during catalysis. The structure of PcpB is not yet known, but based on the structure of phenol 
hydroxylase from Trichosporon cutaneum, which is 20% identical to PcpB, the cysteine residues at 
positions 56, 182, and 302 are predicted to be close to the active site (Figure 4).  
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Figure 4. Structure of one subunit of tetrameric 
phenol hydroxylase from Trichosporon 
cutaneum (PDBID: 1PN0), which is 
homologous to PCP hydroxylase. Residues that 
contact the FAD, phenol, and NADPH are 
shown in purple, black, and cyan, respectively. 
Orange spheres represent FAD. Red spheres 
correspond to cysteine residues in PCP 
hydroxylase. (Courtesy of Dr. Oyeyemi, 
University of Colorado).  
 
This project aims to determine which cysteine residue(s) in the enzyme is/are involved in the 
inactivation of the enzyme by TCBQ. In mutant versions of the enzyme, cysteine residues were changed 
to serine residues. Hopefully, at least one such mutant version of the enzyme will not get inactivated by 
TCBQ and still be able to perform its catalytic function. If a cysteine residue is required for function and 
is involved in the inactivation, then preventing the inactivation by removing this cysteine residue while 
maintaining an enzyme that is still functional is not possible. Upon establishing such a mutant version of 
the enzyme, we will have more insight into the mechanism of inactivation of the enzyme by TCBQ. The 
position of the particular cysteine residue that is mutated will provide insight into the mechanism of 
inactivation. Also, the fact that this mutant version of the enzyme will still be capable of its catalytic 
function would provide some insight into the catalytic mechanism of the enzyme in that the particular 
cysteine residue that is mutated is not required for catalysis. This is part of a larger goal to engineer this 
PCP degradation pathway to be able to clear PCP from the environment more efficiently. 
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Chapter 2: Effect of Changing Cysteines to Serines on Enzyme Activity 
 Wild type, C302S and C537S mutant versions of PcpB were assayed for activity by monitoring 
PCP disappearance by HPLC. Examples of the data are presented in Figure 5. The enzymes were assumed 
to be saturated with PCP at the concentrations tested because the KM for PCP for PcpB is about 2 µM, so 
the KM for the mutant versions of the enzyme are assumed to be the same. Under this assumption, the 
PCP concentrations tested were well above the minimal concentration needed to saturate the enzymes. 
Assays were done only for enzyme saturated with PCP because the peaks at A305 for lower concentrations 
of PCP were too indistinguishable from random noise in the absorption. Values for kcat are given in Table 
1 (n=11 for Wt, n=7 for C302S mutant version, and n=3 for C537S mutant version). Because the C302S 
and C537S mutant versions of PcpB are still functional, none of these cysteine residues is necessary for 
catalysis. 
 
Table 1. Flavin loading and kcat for wild type and mutant versions of PcpB 
PcpB Flavin Loading kcat (sec
-1
) 
Wt 32% 0.017 ± 0.005 
C302S 68% 0.017 ± 0.017 
C537S 38% 0.02 ± 0.013 









Figure 5. Reaction rates for a) PcpB, b) C302S mutant version of PcpB, and c) C537S mutant version of 





Involvement of Cysteine Residues in the Function and Inactivation of PCP Hydroxylase  12 
 
Chapter 3: Inactivation of Enzymes by TCBQ 
PcpB appears to be inactivated after treatment with 500 µM TCBQ for 60 minutes. This was 
confirmed by monitoring PCP consumption by HPLC (n=11 for untreated PcpB, n=9 for TCBQ-treated 
PcpB). Examples of the data are presented in Figure 6. When monitoring PCP consumption by HPLC, 
reduced reaction rates were observed for TCBQ-treated enzyme (Table 2). 
 
Table 2. kcat, PCP for wild type and mutant versions of PcpB treated with 500 µM TCBQ for 60 minutes and 
enzymes not treated with TCBQ
 








Wt expressed in Tuner (DE3) 0.0038 ± 0.004 0.017 ± 0.005 
C302S expressed in M15[pRep4] 
C537S expressed in M15[pRep4] 
0.0005 ± 0.0006 
0.0073 ± 0.0017 
0.017 ± 0.017 








Figure 6. Reaction rates for a) PcpB after treatment with TCBQ, b) C302S mutant version of PcpB after 
treatment with TCBQ, and c) C537S mutant version of PcpB after treatment with TCBQ. The equations 
for best-fit lines are in order by trial. 
 
c 
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Treating the C302S mutant version of PcpB with 500 µM TCBQ for 60 minutes was sufficient to 
inactivate it. PCP turnover rate was followed by HPLC for these TCBQ-treated enzymes (n=7 for 
untreated enzyme, n=2 for TCBQ-treated enzyme) and was also dramatically decreased (Table 2). 
After treating the C537S mutant version of PcpB with 500 µM TCBQ for 60 minutes and 
measuring PCP consumption by HPLC (n=3 for untreated enzyme, n=6 for TCBQ-treated enzyme), this 
enzyme was shown to get only four-fold inactivated under these conditions (Table 2). This enzyme was 
least affected by the treatment with TCBQ among the enzymes assayed. This enzyme may show some 
promise as it does not get inactivated to the same degree as the other versions of PcpB. 
  
Discussion 
A cysteine to serine mutant version of PcpB that is functional and does not get inactivated by 
TCBQ would provide evidence regarding the mechanism of inactivation. If the mutated residue were near 
the active site (Cys56, Cys182, or Cys302), then this would suggest that the TCBQ adduct prevents PCP 
from entering the active site or interferes with the catalytic conformational changes. If the mutated residue 
is far from the active site (Cys40 or Cys537), then this would suggest that the TCBQ adduct interferes 
with the proper conformations or conformational changes of the enzyme.  
It may also be possible that the mechanism of inactivation by TCBQ is not via formation of an 
adduct to the enzyme but, rather, via oxidation of the corresponding cysteine residue(s). If this is the case, 
then the mechanism of inactivation is probably due to an inability for the enzyme to undergo 
conformational changes necessary for catalysis due to the oxidized cysteine(s), This would not suggest 
that the corresponding oxidized cysteine residue must be reduced in order for the enzyme to bind its 
substrates. If the corresponding reduced cysteine residue is required to bind its substrates, then the 
enzyme would not be able to perform catalysis without this cysteine residue even having not been treated 
with TCBQ. 
The results of this study reveal that the C302S, and C537S mutant versions of PcpB are about as 
functional as the wild type version of the enzyme, indicating that these cysteine residues are not necessary 
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for the enzyme to function. However, all these mutants get inactivated at least to some extent after 
treatment with TCBQ, so none of these single cysteine to serine changes is sufficient to prevent this 
inactivation entirely. Still, the C537S mutant version of PcpB may show some promise towards this goal.  
 
Future Directions 
The C40S and C56S mutant versions of PcpB have not yet been assayed. If either of these mutant 
versions of the enzyme is functional and does not get inactivated by TCBQ, then a version of the enzyme 
will have been generated that performs better than the wild type version in that the enzyme does not get 
inactivated by TCBQ. This improved version of the enzyme would be able to continue to catalyze its 
reaction for theoretically infinite turnovers with no danger of inactivation upon the formation of TCBQ. If 
either of these mutants fails to function entirely, even without treatment with TCBQ, then this would 
suggest that the corresponding cysteine that was mutated is necessary for the performance of the enzyme.  
More experiments would then be needed to determine the mechanism by which the enzyme fails 
to function when lacking that corresponding cysteine residue. It may regard binding the substrates or the 
flavin cofactor, or it may be involved directly in the catalytic mechanism or important for structure or 
structural changes involved in catalysis. 
If all of the cysteine mutant versions of the enzyme are functional, then none of the cysteine 
residues in the enzyme is necessary for the enzyme to function. If, however, all of the mutant versions get 
inactivated by TCBQ, then removal of any single cysteine residue is not sufficient to prevent the 
inactivation. If this is the case, then future experiments should involve double and triple mutants, and 
perhaps an enzyme with no cysteine residues. Removing all the cysteine residues would hopefully be 
sufficient to prevent the inactivation. If all single cysteine mutant versions of the enzyme indeed get 
inactivated by TCBQ, then it is also possible that the mechanism of the inactivation does not involve 
cysteine residues. To test this, a version of the enzyme with no cysteine residues should be assayed for 
inactivation. If this version of the enzyme still gets inactivated by TCBQ, then the mechanism of the 
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inactivation does not involve cysteine residues, and more experiments would need to be done to 
determine the correct mechanism of inactivation. 
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Chapter 4: Methods 
Site-Directed Mutagenesis and Sequencing of mutant versions of pcpB 
              Linda Behlen had cloned genes encoding the C40S, C56S, C182S, C302S, and C537S versions 
of PcpB into the vector pQE30 (Figure 7), but they contained a mutation that encodes a proline at residue 
536, where an arginine should be encoded. Quikchange site-directed mutagenesis was used to reverse this 
mutation so that clones of the genes encoding each mutant gene correctly encoded an arginine at residue 
536. The primer 5’-GAG CGA TGC TTG TGC GCT GCG CCT AAG CTT AAT TAG CTG-3’ and its 
reverse complement were used. Each reaction mix was prepared according to the PfuUltra II Fusion HS 
DNA polymerase protocol (Stratagene, 2006), except that each reaction contained 1.5 μL quick solution, 
approximately 125 ng of each primer, and 0.2 mM dNTP mix in a final volume of 50 µL. The quick 
solution was used to help the DNA polymerase with the long template. The Pfu Ultra II fusion DNA 
polymerase has an antibody in its active site, keeping it from functioning at room temperature so that the 
reaction mix can be prepared at room temperature. The parental strands that still contained the unwanted 
mutation, which were methylated, were digested with Dpn1. Because the site-directed mutagenesis and 
Dpn1 digest reactions took place in solutions of high salt, a cleanup of the Dpn1 digest ion products was 
performed using the Omega E. Z. N. A. Cycle Pure Kit spin protocol (p.6-7 in manual).  
 Because the plasmids produced by the site-directed mutagenesis were not supercoiled, they 
were transformed into the E. coli strain NEB10β, which was prepared to have high transformation 
efficiency so that the plasmids were more likely to be taken up by the bacteria. The plasmids were then 
extracted from the transformants using the E. Z. N. A. Plasmid Miniprep Kit and sequenced by 
Macrogenusing the pQEPromotor and pQEReverse primers. Sequences obtained were aligned using the 
EBI ClustalW2 alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html) to confirm that they 
had the desired mutation and the correct sequence otherwise. Plasmids containing desires sequences were 
transformed into the E. coli cloning strain TOP10 using the TSS transformation method (Chung, et. al., 
1988) and were transformed into the E. coli expression strain M15[pRep4] by electroporation. 
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Figure 7. pQE30 plasmid (from Qiagen, 2003, The QIAexpressionist), which has a strong lac promoter, a 
His6-tag, and an ampicillin resistance gene. 
 
Expression and Purification of Wild type and Mutant Versions of PcpB 
 Plasmids were transformed into E. coli strain M15[pRep4] by electroporation using a Bio-Rad 
MicroPulser. This expression strain contains the pRep4 plasmid, which encodes a kanamycin resistance 
gene and strong repressors so that the expression of pcpB gene is tightly repressed until induced. 
Transformants were plated on LB plates containing ampicillin and kanamycin (50 µg/mL each), and one 
colony of each was inoculated into a small overnight culture in LB containing ampicillin and kanamycin. 
After overnight growth at 35-37 
o
C with shaking, each culture was diluted 100-fold into large cultures of 
the same medium for expression. Once the cells reach an OD600 of about 0.6, expression of PCP 
hydroxylase was induced by adding isopropyl--D-thiogalactopyranoside (IPTG) to a concentration of 
100 µM, and the cultures were grown at room temperature with shaking. Aliquots were taken at various 
time points after induction for analysis by SDS-PAGE. Cells were harvested by centrifugation for 10 
minutes at 5000 x g at 7-15 
o
C. The cells were lysed using a French press three times at a cell pressure of 
1135 psi after being resuspended in lysis buffer (50 mM sodium phosphate buffer, pH 8.0, containing 300 
mM NaCl, 10 mM imidazole, 1 mg/mL lysozyme and 25 U/mL Benzonase Nuclease). The lysates were 
then subjected to centrifugation at 20,000 x g at 6-13 
o
C for 30 minutes. PcpB was purified by Ni-NTA 
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chromatography, in which the supernatants from the lysates were applied to the column, the column was 
washed with wash buffer (50 mM sodium phosphate buffer, pH 8.0, containing 300 mM NaCl, and 20 
mM imidazole), and the protein was eluted with elution buffer (50 mM sodium phosphate buffer, pH 8.0, 
containing 300 mM NaCl, and 250 mM imidazole). The purified proteins were dialyzed against 50 mM 
phosphate buffer in 50% glycerol. The enzymes were stored at -20
o
C. The purities of the proteins were 
determined by SDS-PAGE (Figure 8). The glycerol was diluted before assaying the protein. 
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63 kD
 
Figure 8. SDS-PAGE gels of a) C302S and b) C537S mutant versions of PcpB expressed in E. coli strain 
M15[pRep4], showing unpurified lysate and purified protein. The molecular weight of the PcpB 
monomer is 63 kDa. PP refers to the Bio-Rad Precision Plus Protein Standards. 
 
Determination of Flavin and PcpB Concentration 
 Purified enzymes were incubated in 7 M urea in 100 mM Tris-HCl, pH 8.0, for a few seconds 
at room temperature to denature the enzymes and release the flavin. They were diluted to obtain A280 and 
A446 between 0.1 and 0.5, and the concentration of flavin was calculated using Equation 1. 
 




 * 1 cm Eq. 1 
 
PcpB and flavin both absorb at 280 nm. For free flavin, A280 = 2*A446. The extinction coefficient at 280 
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* 1 cm  Eq. 2 
 
For PcpB fully loaded with flavin, the ratio of the concentration of flavin to the concentration of 
monomeric PcpB should be 1:1. The flavin loading for each enzyme was determined by the ratio of the 
concentration of free flavin to the concentration of PcpB obtained from the A280 and A446.  
 
 
Assay for PCP hydroxylase activity 
PCP hydroxylase activity was assayed at room temperature in 100 mM potassium phosphate 
buffer, pH 7.5, containing 300 µM NADPH, PCP hydroxylase, and 50 μM PCP. The KM for PCP for 
PcpB is about 2 µM. The KM for the mutant versions of the enzyme is probably about the same, so the 
enzymes were saturated at 300 µM NADPH and 50 μM PCP. PCP stock solution was prepared according 
to Habeeb (1972). The time courses and enzyme concentrations were adjusted so that 10% of the PCP in 
the reaction mixture was consumed. NADPH stock solutions (10 mM) were prepared fresh each day. The 
PCP stock solution was vortexed before addition to the reaction tube. Aliquots from various time points 
were incubated in a sand bath at 130-150 ºC for three minutes to quench the reaction and centrifuged at 
16,100 x g for 5 minutes to remove precipitated PcpB prior to analysis by HPLC. Disappearance of PCP 
was followed by HPLC on a reverse-phase Zorbaxb-SB C-18 column (150 mm x 4.6 mm; Agilent) using 
an Agilent 1100 HPLC system and detection at 305 nm. The column was equilibrated with 80% 0.01 M 
phosphoric acid and 20% acetonitrile. A gradient elution method was used with a 0.01 M phosphoric acid 
and acetonitrile mixture, from 20 to 45% acetonitrile for the first 7.5 minutes, and 45 to 80% acetonitrile 
for 2 minutes at a flow rate of 1.5 mL/min. The retention time of PCP was 11.6 minutes.  The activity was 
considered in terms of flavin concentration, not enzyme concentration, because the enzyme without flavin 
is inactive. Formation of product (TCBQ) cannot be followed because it can be nonenzymatically reduced 
to TCHQ by NADPH in the reaction mixture, and some may covalently attach to cysteine residues on the 
enzyme. 
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Inactivation of Wild Type and Mutant PcpB by TCBQ 
 Enzymes (5 μM) were treated with 500 μM TCBQ in 100 mM phosphate buffer, pH 7.5 for 60 
minutes at room temperature. TCBQ stock solutions (10 mM) were prepared fresh in acetone The reaction 
mixtures were then diluted three-fold into 100 mM phosphate buffer, pH 7.5. The solutions were filtered 
through Millipore centrifugal filter units to remove any excess TCBQ. The TCBQ-treated and untreated 
enzymes were assayed for activity as described above 
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